|
Huangshan Roman Co., Ltd (002014.SZ) DCF -Bewertung
CN | Consumer Cyclical | Packaging & Containers | SHZ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Huangshan Novel Co.,Ltd (002014.SZ) Bundle
Bewerten Sie Huangshan Roman Co., Ltds finanzielle Aussichten wie ein Experte! Dieser DCF-Taschenrechner (002014SZ) bietet vorgefüllte Finanzdaten und bietet Ihnen die Freiheit, das Umsatzwachstum, WACC, Margen und andere wichtige Annahmen zu ändern, um sich an Ihren Projektionen auszurichten.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,599.7 | 2,737.5 | 3,023.7 | 3,304.1 | 3,378.8 | 3,609.3 | 3,855.5 | 4,118.6 | 4,399.5 | 4,699.7 |
| Revenue Growth, % | 0 | 5.3 | 10.45 | 9.27 | 2.26 | 6.82 | 6.82 | 6.82 | 6.82 | 6.82 |
| EBITDA | 412.4 | 467.9 | 490.6 | 548.4 | 631.6 | 609.8 | 651.4 | 695.8 | 743.3 | 794.0 |
| EBITDA, % | 15.86 | 17.09 | 16.22 | 16.6 | 18.69 | 16.89 | 16.89 | 16.89 | 16.89 | 16.89 |
| Depreciation | 97.5 | 109.9 | 121.1 | 126.4 | 150.3 | 144.7 | 154.5 | 165.1 | 176.3 | 188.4 |
| Depreciation, % | 3.75 | 4.01 | 4 | 3.82 | 4.45 | 4.01 | 4.01 | 4.01 | 4.01 | 4.01 |
| EBIT | 314.9 | 358.1 | 369.5 | 422.0 | 481.3 | 465.1 | 496.8 | 530.7 | 566.9 | 605.6 |
| EBIT, % | 12.11 | 13.08 | 12.22 | 12.77 | 14.24 | 12.89 | 12.89 | 12.89 | 12.89 | 12.89 |
| Total Cash | 763.1 | 1,086.5 | 817.9 | 1,212.7 | 1,479.9 | 1,274.8 | 1,361.7 | 1,454.6 | 1,553.9 | 1,659.9 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 555.3 | 550.0 | 667.0 | 625.3 | 706.6 | 746.0 | 796.9 | 851.3 | 909.4 | 971.4 |
| Account Receivables, % | 21.36 | 20.09 | 22.06 | 18.93 | 20.91 | 20.67 | 20.67 | 20.67 | 20.67 | 20.67 |
| Inventories | 266.5 | 243.1 | 332.7 | 343.6 | 302.8 | 357.3 | 381.6 | 407.7 | 435.5 | 465.2 |
| Inventories, % | 10.25 | 8.88 | 11 | 10.4 | 8.96 | 9.9 | 9.9 | 9.9 | 9.9 | 9.9 |
| Accounts Payable | 412.1 | 439.6 | 281.9 | 488.6 | 432.7 | 496.8 | 530.7 | 566.9 | 605.6 | 646.9 |
| Accounts Payable, % | 15.85 | 16.06 | 9.32 | 14.79 | 12.81 | 13.77 | 13.77 | 13.77 | 13.77 | 13.77 |
| Capital Expenditure | -163.5 | -261.3 | -240.6 | -308.4 | -109.7 | -262.5 | -280.5 | -299.6 | -320.0 | -341.9 |
| Capital Expenditure, % | -6.29 | -9.55 | -7.96 | -9.33 | -3.25 | -7.27 | -7.27 | -7.27 | -7.27 | -7.27 |
| Tax Rate, % | 11.49 | 11.49 | 11.49 | 11.49 | 11.49 | 11.49 | 11.49 | 11.49 | 11.49 | 11.49 |
| EBITAT | 274.8 | 310.6 | 324.3 | 375.5 | 426.0 | 408.6 | 436.5 | 466.2 | 498.1 | 532.0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -200.9 | 215.3 | -159.4 | 430.9 | 370.3 | 260.9 | 269.2 | 287.5 | 307.2 | 328.1 |
| WACC, % | 5.8 | 5.79 | 5.8 | 5.8 | 5.8 | 5.8 | 5.8 | 5.8 | 5.8 | 5.8 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 1,222.6 | |||||||||
| Long Term Growth Rate, % | 3.00 | |||||||||
| Free cash flow (T + 1) | 338 | |||||||||
| Terminal Value | 12,076 | |||||||||
| Present Terminal Value | 9,110 | |||||||||
| Enterprise Value | 10,333 | |||||||||
| Net Debt | -466 | |||||||||
| Equity Value | 10,798 | |||||||||
| Diluted Shares Outstanding, MM | 609 | |||||||||
| Equity Value Per Share | 17.73 |
Benefits You Will Receive
- Comprehensive Financial Model: Leverage Huangshan Novel Co., Ltd's actual data for accurate DCF valuation.
- Complete Forecast Management: Modify key drivers such as revenue growth, profit margins, WACC, and more.
- Real-Time Calculations: Automatic updates provide immediate feedback as adjustments are made.
- Professional-Grade Template: A polished Excel file prepared for serious investment analysis.
- Flexible and Reusable: Designed for adaptability, making it easy to use for multiple detailed forecasts.
Key Features
- Pre-Loaded Data: Historical financial statements and pre-filled forecasts for Huangshan Novel Co., Ltd (002014SZ).
- Fully Adjustable Inputs: Customize WACC, tax rates, revenue growth, and EBITDA margins.
- Instant Results: Witness the intrinsic value of Huangshan Novel Co., Ltd (002014SZ) recalculate in real time.
- Clear Visual Outputs: Dashboard charts showcase valuation results and essential metrics.
- Built for Accuracy: A professional-grade tool designed for analysts, investors, and finance professionals.
How It Functions
- Step 1: Download the prebuilt Excel template containing Huangshan Novel Co., Ltd's (002014SZ) data.
- Step 2: Navigate through the pre-filled sheets to familiarize yourself with the essential metrics.
- Step 3: Update forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
- Step 4: Instantly view recalculated results, including the intrinsic value of Huangshan Novel Co., Ltd (002014SZ).
- Step 5: Make well-informed investment decisions or create reports based on the outputs.
Why Opt for Huangshan Novel Co., Ltd’s Calculator?
- Time-Efficient: Utilize a pre-built DCF model—no need to start from square one.
- Enhanced Precision: Dependable financial data and formulas minimize valuation inaccuracies.
- Completely Adaptable: Modify the model to align with your specific assumptions and forecasts.
- User-Friendly: Intuitive charts and outputs facilitate straightforward analysis of results.
- Preferred by Professionals: Crafted for experts who prioritize both accuracy and ease of use.
Who Can Benefit from This Product?
- Finance Students: Master valuation techniques and apply them using real market data.
- Researchers: Integrate industry-standard models into your studies or research projects.
- Investors: Validate your investment strategies and assess the valuation metrics for Huangshan Novel Co.,Ltd (002014SZ).
- Financial Analysts: Enhance your efficiency with a customizable DCF model designed for precise analysis.
- Entrepreneurs: Learn how major public companies like Huangshan Novel Co.,Ltd (002014SZ) are evaluated in the market.
Contents of the Template
- Pre-Filled DCF Model: Huangshan Novel Co., Ltd.’s financial data preloaded for immediate analysis.
- WACC Calculator: Comprehensive calculations for Weighted Average Cost of Capital.
- Financial Ratios: Assess Huangshan Novel Co., Ltd.’s profitability, leverage, and operational efficiency.
- Editable Inputs: Modify assumptions such as growth, margins, and CAPEX to match your specific scenarios.
- Financial Statements: Annual and quarterly reports available for in-depth analysis.
- Interactive Dashboard: Effortlessly visualize essential valuation metrics and outcomes.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.